Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Amoxycillin 400mg + Clavulanate 57mg Syrup, Strength: 228.5 mg/5 ml

₹ 120/Bottle

Strength228.5 mg/5 ml
Pack Size30 ml
UsagePaediatric
BrandPureclav -DS
FormSyrup
Packaging TypeBottle
Packaging Size30ml
AvailabilityIn Stock
View in Hindi एमोक्सिसिलिन 400 मि.ग्रा. + क्लैव्युलेनेट 57 मि.ग्रा. सिरप, स्ट्रेंथ: 228.5 मि.ग्रा./5 मि.ली.
ATE DISPLAYED ABOVE IS MAXIMUM RETAIL PRICE(MRP) FOR THE SELLING PRICE. PLEASE CONTACT US FOR MORE DETAILS.

Exports To: United States Of America | Afghanistan | Sri Lanka | Germany | Iraq

Find products similar to Amoxycillin 400mg + Clavulanate 57mg Syrup, Strength: 228.5 Mg/5 Ml

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNew Delhi
ShippingAs per delivery location

Product Video

Product Image

Amoxycillin 400mg + Clavulanate 57mg Syrup, Strength: 228.5 mg/5 ml-1Amoxycillin 400mg + Clavulanate 57mg Syrup, Strength: 228.5 mg/5 ml-2Amoxycillin 400mg + Clavulanate 57mg Syrup, Strength: 228.5 mg/5 ml-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
19-12-2022
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Mar 2023
GST
07AAIPN3096P2ZY
Import Export Code (IEC)
AAIPN*****
Exports to
United States Of America | Afghanistan | Sri Lanka | Germany | Iraq

Established in the year 2022, we “Arvantis Pharmaceuticals” are Wholesaler/Distributor of a Medicine. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Gopal Dass Nagpal, whose continual backing and direction have been useful to us for attaining exponential development in the current market.